These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 6126117)
41. Crithidia luciliae assay for antibodies to native DNA in procainamide-induced lupus erythematosus. Dixon JA; Mulhern LM; Whiteside TL; Luksick J J Rheumatol; 1980; 7(4):544-6. PubMed ID: 6999152 [TBL] [Abstract][Full Text] [Related]
42. [Results of treatment with sulfasalazine in the American Multicenter Study on the treatment of Crohn disease (National Cooperative Crohn's Disease Study)]. Singleton JW Z Gastroenterol Verh; 1981 Jun; 19():38-40. PubMed ID: 6168133 [No Abstract] [Full Text] [Related]
44. [Crohn's disease with isolated vulvar localization and pregnancy. A case report]. Bitri M; Chelly H; Ben Osmane A; Haouet S J Gynecol Obstet Biol Reprod (Paris); 1994; 23(6):712-6. PubMed ID: 7995918 [TBL] [Abstract][Full Text] [Related]
45. [Crohn's disease associated with focal pulmonare lesion]. Tagle M; Barriga J; Piñeiro A Rev Gastroenterol Peru; 2003; 23(4):293-6. PubMed ID: 14716424 [TBL] [Abstract][Full Text] [Related]
46. The influence of inflammatory bowel disease and its treatment on pregnancy and fetal outcome. Baiocco PJ; Korelitz BI J Clin Gastroenterol; 1984 Jun; 6(3):211-6. PubMed ID: 6144706 [TBL] [Abstract][Full Text] [Related]
47. [Clinical effect of salazosulfapyridine (salazopyrin) in Crohn's disease. A controlled double-blind investigation]. Anthonisen P; Bárány F; Folkenborg O; Holtz A; Jarnum S; Kristensen M; Riis P; Walan A; Worning H Ugeskr Laeger; 1974 Aug; 136(32):1798-802. PubMed ID: 4153180 [No Abstract] [Full Text] [Related]
48. Anti-double stranded DNA and lupus syndrome induced by interferon-beta therapy in a patient with multiple sclerosis. Bonaci-Nikolic B; Jeremic I; Andrejevic S; Sefik-Bukilica M; Stojsavljevic N; Drulovic J Lupus; 2009 Jan; 18(1):78-80. PubMed ID: 19074173 [TBL] [Abstract][Full Text] [Related]
49. [Erythema nodosum and Crohn's disease]. Areias E; García E Silva L Med Cutan Ibero Lat Am; 1984; 12(6):489-95. PubMed ID: 6152299 [TBL] [Abstract][Full Text] [Related]
50. Medical therapy to reduce postoperative Crohn's disease recurrence. Achkar JP; Hanauer SB Am J Gastroenterol; 2000 May; 95(5):1139-46. PubMed ID: 10811318 [TBL] [Abstract][Full Text] [Related]
51. Localized epidermolysis bullosa acquisita of the esophagus in a patient with Crohn's disease. Schattenkirchner S; Lémann M; Prost C; Caux F; Guigui B; Cadot M; Bertheau P; Grateau C; Heller M Am J Gastroenterol; 1996 Aug; 91(8):1657-9. PubMed ID: 8759686 [TBL] [Abstract][Full Text] [Related]
52. [Prevalence and role of anticardiolipin antibodies in Crohn disease]. Lonjon I; Beaugerie L; Deschamps A; Barthet C; Carbonnel F; Ngô Y; Cosnes J; Abuaf N; Gendre JP Gastroenterol Clin Biol; 1996; 20(8-9):633-7. PubMed ID: 8977809 [TBL] [Abstract][Full Text] [Related]
53. Current treatment for prevention of relapse and recurrence in Crohn's disease. Prantera C; Scribano ML Ital J Gastroenterol Hepatol; 1999; 31(6):515-8. PubMed ID: 10575572 [TBL] [Abstract][Full Text] [Related]
54. [Systemic lupus erythematosus induced by anticonvulsivant drug (author's transl)]. Tor J; Rey C; Fernández-Sevilla T; Martí Vilalta JL Med Clin (Barc); 1979 Dec; 73(10):443-6. PubMed ID: 93671 [TBL] [Abstract][Full Text] [Related]
55. Lymphocytic lymphoma and systemic lupus erythematosus: their coexistence with antibody to the Sm antigen. McCarty GA; Rice JR; Fetter BF; Pisetsky DS Arch Pathol Lab Med; 1982 Apr; 106(4):196-9. PubMed ID: 6175291 [TBL] [Abstract][Full Text] [Related]
58. Does sulphasalazine cause drug induced systemic lupus erythematosus? No effect evident in a prospective randomised trial of 200 rheumatoid patients treated with sulphasalazine or auranofin over five years. Gordon MM; Porter DR; Capell HA Ann Rheum Dis; 1999 May; 58(5):288-90. PubMed ID: 10225813 [TBL] [Abstract][Full Text] [Related]
59. [Pulmonary diffusing capacity disorder in nonspecific intestinal inflammations unexplainable by acetylation phenotype or treatment with sulfasalazine]. Bures J; Horácek J; Tilser P; Fixa B; Komárková O; Tichý M; Zaydlar K; Král B Cas Lek Cesk; 1986 Jul; 125(29):905-9. PubMed ID: 2873894 [No Abstract] [Full Text] [Related]
60. [A new case of lupus induced by acebutolol]. Hourdebaigt-Larrusse P; Ziza JM; Grivaux M Ann Cardiol Angeiol (Paris); 1985 Jun; 34(6):421-3. PubMed ID: 3875307 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]